Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial.

Kelbæk H, Høfsten DE, Køber L, Helqvist S, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamäki K, De Backer O, Bang LE, Kofoed KF, Lønborg J, Ahtarovski K, Vejlstrup N, Bøtker HE, Terkelsen CJ, Christiansen EH, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Jensen LO, Clemmensen P, Grande P, Madsen JK, Torp-Pedersen C, Engstrøm T.

Lancet. 2016 Apr 1. pii: S0140-6736(16)30072-1. doi: 10.1016/S0140-6736(16)30072-1. [Epub ahead of print]

PMID:
27053444
2.

Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IV.

Jensen LO, Thayssen P, Christiansen EH, Maeng M, Ravkilde J, Hansen KN, Hansen HS, Krusell L, Kaltoft A, Tilsted HH, Berencsi K, Junker A, Lassen JF; SORT OUT IV Investigators.

J Am Coll Cardiol. 2016 Feb 23;67(7):751-62. doi: 10.1016/j.jacc.2015.11.051.

PMID:
26892409
3.

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.

Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamäki K, Clemmensen P, De Backer O, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Køber L; DANAMI-3—PRIMULTI Investigators.

Lancet. 2015 Aug 15;386(9994):665-71.

PMID:
26347918
4.

Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction.

Jensen LO, Terkelsen CJ, Horváth-Puhó E, Tilsted HH, Maeng M, Junker A, Lassen JF, Thuesen L, Sørensen HT, Thayssen P.

Am Heart J. 2015 Jul;170(1):70-8. doi: 10.1016/j.ahj.2015.03.020. Epub 2015 Apr 2.

PMID:
26093866
5.

Decreased patency rates following endoscopic vein harvest in coronary artery bypass surgery.

Andreasen JJ, Vadmann H, Oddershede L, Tilsted HH, Frøkjær JB, Jensen SE.

Scand Cardiovasc J. 2015;49(5):286-92.

PMID:
26053411
6.

Prehospital administration of P2Y12 inhibitors and early coronary reperfusion in primary PCI: an observational comparative study.

De Backer O, Ratcovich H, Biasco L, Pedersen F, Helqvist S, Saunamäki K, Tilsted HH, Clemmensen P, Olivecrona G, Kelbaek H, Jørgensen E, Engstrøm T, Holmvang L.

Thromb Haemost. 2015 Aug 31;114(3):623-31. doi: 10.1160/TH15-01-0026. Epub 2015 May 21.

PMID:
25994355
7.

The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treatment of culprit lesion only: Rationale and design of the DANAMI 3 trial program.

Høfsten DE, Kelbæk H, Helqvist S, Kløvgaard L, Holmvang L, Clemmensen P, Torp-Pedersen C, Tilsted HH, Bøtker HE, Jensen LO, Køber L, Engstrøm T; DANAMI 3 Investigators.

Am Heart J. 2015 May;169(5):613-21. doi: 10.1016/j.ahj.2015.02.004. Epub 2015 Feb 14.

PMID:
25965708
8.

To Aspirate or Not to Aspirate: That Is the Question.

Tilsted HH, Olivecrona GK.

JACC Cardiovasc Interv. 2015 Apr 20;8(4):585-7. doi: 10.1016/j.jcin.2015.01.014. No abstract available.

9.

Underuse of an invasive strategy for patients with diabetes with acute coronary syndrome: a nationwide study.

Gustafsson I, Hvelplund A, Hansen KW, Galatius S, Madsen M, Jensen JS, Tilsted HH, Terkelsen CJ, Jensen LO, Jørgensen E, Madsen JK, Abildstrøm SZ.

Open Heart. 2015 Feb 6;2(1):e000165. doi: 10.1136/openhrt-2014-000165. eCollection 2015.

10.

The Western Denmark Cardiac Computed Tomography Registry: a review and validation study.

Nielsen LH, Nørgaard BL, Tilsted HH, Sand NP, Jensen JM, Bøttcher M, Diederichsen AC, Lambrechtsen J, Kristensen LD, Mickley H, Munkholm H, Gøtzsche O, Knudsen LL, Bøtker HE, Pedersen L, Schmidt M.

Clin Epidemiol. 2014 Dec 31;7:53-64. doi: 10.2147/CLEP.S73728. eCollection 2015. Review.

11.

A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).

Maeng M, Baranauskas A, Christiansen EH, Kaltoft A, Holm NR, Krusell LR, Ravkilde J, Tilsted HH, Thayssen P, Jensen LO.

Catheter Cardiovasc Interv. 2015 Dec 1;86(7):1161-7. doi: 10.1002/ccd.25875. Epub 2015 May 6.

PMID:
25640050
12.

Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial.

Raungaard B, Jensen LO, Tilsted HH, Christiansen EH, Maeng M, Terkelsen CJ, Krusell LR, Kaltoft A, Kristensen SD, Bøtker HE, Thuesen L, Aarøe J, Jensen SE, Villadsen AB, Thayssen P, Veien KT, Hansen KN, Junker A, Madsen M, Ravkilde J, Lassen JF; Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT).

Lancet. 2015 Apr 18;385(9977):1527-35. doi: 10.1016/S0140-6736(14)61794-3. Epub 2015 Jan 16. Erratum in: Lancet. 2015 Apr 18;385(9977):1510.

PMID:
25601789
13.

Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: a nationwide study in Denmark.

Jabbari R, Engstrøm T, Glinge C, Risgaard B, Jabbari J, Winkel BG, Terkelsen CJ, Tilsted HH, Jensen LO, Hougaard M, Chiuve SE, Pedersen F, Svendsen JH, Haunsø S, Albert CM, Tfelt-Hansen J.

J Am Heart Assoc. 2015 Jan 5;4(1):e001399. doi: 10.1161/JAHA.114.001399. Erratum in: J Am Heart Assoc. 2015 Jul;4(7). pii: e000738. doi: 10.1161/JAHA.115.000738.

14.

Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a Danish organization for randomized trials on clinical outcome III substudy).

Olesen KK, Tilsted HH, Jensen LO, Kaltoft A, Krusell LR, Ravkilde J, Christiansen EH, Madsen M, Thayssen P, Sørensen HT, Lassen JF, Maeng M.

Am J Cardiol. 2015 Feb 1;115(3):298-302. doi: 10.1016/j.amjcard.2014.10.038. Epub 2014 Nov 11.

PMID:
25499925
15.

Coronary computed tomography angiography without significant stenosis predicts favourable three-year prognosis.

Kristiansen JM, Zaremba T, Johansen MB, Tilsted HH, Jensen SE.

Dan Med J. 2014 Aug;61(8):A4884.

PMID:
25162443
16.

Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study.

Thim T, Johansen MB, Chisholm GE, Schmidt M, Kaltoft A, Sørensen HT, Thuesen L, Kristensen SD, Bøtker HE, Krusell LR, Lassen JF, Thayssen P, Jensen LO, Tilsted HH, Maeng M.

BMC Cardiovasc Disord. 2014 Aug 13;14:100. doi: 10.1186/1471-2261-14-100.

17.

Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial.

Jensen LO, Thayssen P, Maeng M, Christiansen EH, Ravkilde J, Hansen KN, Kaltoft A, Tilsted HH, Madsen M, Lassen JF; Scandinavian Organization for Randomized Trials With Clinical Outcome SORT OUT IV Investigators.

JACC Cardiovasc Interv. 2014 Aug;7(8):840-8. doi: 10.1016/j.jcin.2014.02.014. Epub 2014 Jul 30.

18.

24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis.

Würtz M, Hvas AM, Jensen LO, Kaltoft AK, Tilsted HH, Kristensen SD, Grove EL.

Int J Cardiol. 2014 Aug 1;175(2):274-9. doi: 10.1016/j.ijcard.2014.05.013. Epub 2014 May 16.

PMID:
24861258
19.

Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.

Maeng M, Tilsted HH, Jensen LO, Krusell LR, Kaltoft A, Kelbæk H, Villadsen AB, Ravkilde J, Hansen KN, Christiansen EH, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Thuesen L, Madsen M, Thayssen P, Sørensen HT, Lassen JF.

Lancet. 2014 Jun 14;383(9934):2047-56. doi: 10.1016/S0140-6736(14)60405-0. Epub 2014 Mar 14.

PMID:
24631162
20.

Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.

Hougaard M, Thayssen P, Kaltoft A, Tilsted HH, Maeng M, Lassen JF, Thuesen L, Okkels Jensen L.

Catheter Cardiovasc Interv. 2014 Jun 1;83(7):1035-42. doi: 10.1002/ccd.25279. Epub 2013 Dec 5.

PMID:
24311384
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk